From the Department of Neurology, Norman Fixel Institute for Neurological Diseases (T.T., Z.J., P.R.Z., M.J.B., M.S.O., A.W.S.), and Department of Neurosurgery (K.D.F.), University of Florida, Gainesville, FL.
Neurology. 2020 Mar 10;94(10):e1073-e1084. doi: 10.1212/WNL.0000000000008875. Epub 2020 Feb 11.
To assess longitudinal tremor outcomes with ventral intermediate nucleus deep brain stimulation (VIM DBS) in patients with dystonic tremor (DT) and to compare with DBS outcomes in essential tremor (ET).
We retrospectively investigated VIM DBS outcomes for 163 patients followed at our center diagnosed with either DT or ET. The Fahn-Tolosa-Marin tremor rating scale (TRS) was used to assess change in tremor and activities of daily living (ADL) at 6 months, 1 year, 2-3 years, 4-5 years, and ≥6 years after surgery.
Twenty-six patients with DT and 97 patients with ET were analyzed. Compared to preoperative baseline, there were significant improvements in TRS motor up to 4-5 years (52.2%; = 0.032) but this did not reach statistical significance at ≥6 years (46.0%, = 0.063) in DT, which was comparable to the outcomes in ET. While the improvements in the upper extremity tremor, head tremor, and axial tremor were also comparable between DT and ET throughout the follow-up, the ADL improvements in DT were lost at 2-3 years follow-up.
Overall, tremor control with VIM DBS in DT and ET was comparable and remained sustained at long term likely related to intervention at the final common node in the pathologic tremor network. However, the long-term ADL improvements in DT were not sustained, possibly due to inadequate control of concomitant dystonia symptoms. These findings from a large cohort of DT indicate that VIM targeting is reasonable if the tremor is considerably more disabling than the dystonic features.
This study provides Class IV evidence that VIM DBS improves tremor in patients with DT or ET.
评估腹侧中间核深部脑刺激(VIM DBS)治疗肌张力障碍性震颤(DT)患者的震颤纵向转归,并与特发性震颤(ET)的 DBS 结果进行比较。
我们回顾性调查了在我们中心接受 VIM DBS 治疗的 163 例诊断为 DT 或 ET 的患者的结果。使用 Fahn-Tolosa-Marin 震颤评定量表(TRS)评估术后 6 个月、1 年、2-3 年、4-5 年和≥6 年时震颤和日常生活活动(ADL)的变化。
分析了 26 例 DT 患者和 97 例 ET 患者。与术前基线相比,DT 患者在 4-5 年时 TRS 运动评分有显著改善(52.2%, = 0.032),但在≥6 年时无显著改善(46.0%, = 0.063),与 ET 结果相当。尽管在整个随访过程中,DT 和 ET 之间上肢震颤、头部震颤和轴向震颤的改善也相当,但 DT 的 ADL 改善在 2-3 年随访时丧失。
总体而言,VIM DBS 治疗 DT 和 ET 的震颤控制相当,且可能与病理性震颤网络中的终末共同节点干预有关,长期持续。然而,DT 的长期 ADL 改善并未持续,可能是由于同时存在的肌张力障碍症状控制不足。这项来自大型 DT 队列的研究结果表明,如果震颤比肌张力障碍特征更严重,那么 VIM 靶向治疗是合理的。
这项研究提供了 IV 级证据,表明 VIM DBS 可改善 DT 或 ET 患者的震颤。